Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
    • ADVERT
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
    • ADVERT
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
    • ADVERT
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Or register via social media

Already have an account? Login here

Or register via social media

Already have an account? Login here

Most searched
  • ask the experts
  • aacr
  • asco
  • IMpower150
  • research

Drug Development

  • 7 Feb 2019 Clinical trials

    Isatuximab meets primary endpoint in Phase III multiple myeloma trial

  • 1 Feb 2019 CAR-T therapy

    NICE approves CAR-T therapy Kymriah® for diffuse large B-cell lymphoma in adults

  • 22 Jan 2019 Targeted therapies

    Future Oncology: best of 2018

  • 15 Jan 2019 Gastrointestinal

    JAVELIN Gastric 100: exploring maintenance avelumab vs first-line chemotherapy in gastric cancer

  • 9 Jan 2019 Chemotherapy

    HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV

  • 6 Dec 2018 News

    Palbociclib halts tumor growth in early breast cancer patients

  • 5 Dec 2018 Hematologic

    ASH 2018 round-up: practice-changing data for leukemia subtype and more

  • 4 Dec 2018 Personalized medicine

    Delays in licensing are denying cancer patients access to innovative treatments

  • 3 Dec 2018 Head and neck

    Pembrolizumab extends survival for advanced head and neck cancer patients

  • 30 Nov 2018 Chemotherapy

    A three-drug antiemetic regimen including GERSC, rather than palonosetron, may lead to a reduction in the number hydration events required by patients receiving emetogenic chemotherapy

  • 30 Nov 2018 Skin

    PD-1 immunotherapy, nivolumab, made available on the NHS for melanoma patients

  • 23 Nov 2018 Lung

    Keytruda® gets the green light from NICE for untreated lung cancer

View More
  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Find a job

    Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

    Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Find a job

      Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

      Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central